Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk InnoCare Pharma Limited per 2025 Jun 30 adalah 1,321.14 MM.
- Nilai operating income untuk InnoCare Pharma Limited per 2025 Jun 30 adalah -378.39 MM.
- Nilai net income untuk InnoCare Pharma Limited per 2025 Jun 30 adalah -208.88 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 1,321.14 | -378.39 | -208.88 |
2025-03-31 | 1,224.89 | -402.87 | -280.26 |
2024-12-31 | 1,009.45 | -544.71 | -440.63 |
2024-09-30 | 898.92 | -580.38 | -375.51 |
2024-06-30 | 780.73 | -652.23 | -470.89 |
2024-03-31 | 714.97 | -725.06 | -761.26 |
2023-12-31 | 738.54 | -671.67 | -631.26 |
2023-09-30 | 721.15 | -755.04 | -583.61 |
2023-06-30 | 757.00 | -765.31 | -867.46 |
2023-03-31 | 695.67 | -736.74 | -780.76 |
2022-12-31 | 625.40 | -777.40 | -886.59 |
2022-09-30 | 503.22 | -772.13 | -986.61 |
2022-06-30 | 1,187.33 | -231.89 | -296.47 |
2022-03-31 | 1,111.32 | -193.26 | -78.08 |
2021-12-31 | 1,043.03 | -182.53 | -64.55 |
2021-09-30 | 981.74 | -55.44 | 59.61 |
2021-06-30 | 102.27 | -550.26 | -266.03 |
2021-03-31 | 51.82 | -554.62 | -328.71 |
2020-12-31 | 1.36 | -558.99 | -391.39 |
2020-09-30 | 1.46 | -511.41 | -1,852.56 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | -0.22 | -0.22 |
2024-06-30 | -0.28 | -0.28 |
2024-03-31 | -0.41 | -0.41 |
2023-12-31 | -0.37 | -0.37 |
2023-09-30 | -0.34 | -0.34 |
2023-06-30 | -0.54 | -0.54 |
2023-03-31 | -0.55 | -0.55 |
2022-12-31 | -0.60 | -0.60 |
2022-09-30 | ||
2022-06-30 | -0.21 | -0.21 |
2022-03-31 | -0.06 | -0.06 |
2021-12-31 | -0.05 | |
2021-09-30 | ||
2021-06-30 | -0.21 | -0.21 |
2021-03-31 | -0.30 | -0.30 |
2020-12-31 | -0.40 | |
2020-09-30 | -1.44 | -1.44 |
2020-06-30 | -4.14 | -4.14 |
2020-03-31 | -5.73 | -5.73 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk InnoCare Pharma Limited per 2025 Jun 30 adalah -144.84 MM.
- Nilai cash from investing activities untuk InnoCare Pharma Limited per 2025 Jun 30 adalah 1,291.21 MM.
- Nilai kas dari aktivitas pendanaan untuk InnoCare Pharma Limited per 2025 Jun 30 adalah -224.70 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -144.84 | 1,291.21 | -224.70 |
2025-03-31 | -224.98 | 686.67 | -245.40 |
2024-12-31 | -365.55 | 1,111.13 | -285.59 |
2024-09-30 | -552.48 | 369.12 | -268.22 |
2024-06-30 | -638.44 | -1,082.01 | -32.52 |
2024-03-31 | -594.73 | 1,165.65 | 2.03 |
2023-12-31 | -665.49 | 661.06 | 1.31 |
2023-09-30 | -616.38 | 1,642.58 | -3.68 |
2023-06-30 | -681.55 | 1,190.45 | 2,790.82 |
2023-03-31 | -582.37 | -114.96 | 3,094.85 |
2022-12-31 | -565.55 | -1,726.35 | 3,094.51 |
2022-09-30 | -508.24 | -2,811.84 | 3,145.45 |
2022-06-30 | 149.50 | 103.11 | 331.29 |
2022-03-31 | 117.09 | -1,780.97 | 1,277.07 |
2021-12-31 | 167.06 | -1,729.96 | 2,544.81 |
2021-09-30 | 238.79 | -256.13 | 2,503.26 |
2021-06-30 | -258.42 | -2,364.49 | 2,514.23 |
2021-03-31 | -215.47 | -1,735.72 | 2,376.10 |
2020-12-31 | -172.52 | -1,106.95 | 2,237.97 |
2020-09-30 | -148.33 | -1,800.55 | 2,238.14 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk InnoCare Pharma Limited pada 2025 Jun 30 adalah -0.03.
- roe untuk InnoCare Pharma Limited pada 2025 Jun 30 adalah -0.03.
- roic untuk InnoCare Pharma Limited pada 2025 Jun 30 adalah -0.03.
- croic untuk InnoCare Pharma Limited pada 2025 Jun 30 adalah 0.03.
- ocroic untuk InnoCare Pharma Limited pada 2025 Jun 30 adalah -0.03.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.03 | -0.03 | -0.03 | 0.03 | -0.03 |
2025-03-31 | -0.05 | -0.04 | -0.05 | -0.06 | -0.07 |
2024-12-31 | -0.04 | -0.06 | -0.04 | -0.05 | -0.06 |
2024-09-30 | -0.05 | -0.05 | -0.05 | -0.18 | -0.06 |
2024-06-30 | -0.07 | -0.10 | -0.08 | 0.06 | -0.06 |
2024-03-31 | -0.06 | -0.08 | -0.07 | 0.00 | -0.08 |
2023-12-31 | -0.06 | -0.07 | -0.06 | 0.11 | -0.07 |
2023-09-30 | -0.11 | -0.16 | -0.08 | 0.33 | -0.07 |
2023-06-30 | -0.10 | -0.16 | -0.10 | 0.38 | -0.08 |
2023-03-31 | -0.12 | -0.14 | -0.09 | 0.28 | -0.06 |
2022-12-31 | -0.14 | -0.18 | -0.12 | -0.00 | -0.06 |
2022-09-30 | -0.04 | -0.17 | -0.11 | -0.00 | -0.05 |
2022-06-30 | -0.01 | -0.05 | -0.04 | 0.09 | 0.01 |
2022-03-31 | -0.01 | -0.03 | -0.03 | -0.06 | 0.02 |
2021-12-31 | -0.07 | -0.02 | -0.01 | 0.14 | -0.04 |
2021-09-30 | -0.05 | -0.08 | -0.03 | 0.34 | -0.04 |
2021-06-30 | -0.07 | -0.10 | -0.05 | -0.06 | -0.04 |
2021-03-31 | -0.08 | -0.12 | -0.06 | 0.02 | -0.03 |
2020-12-31 | -0.18 | -0.11 | 0.16 | -0.04 | |
2020-09-30 | -0.72 | -0.44 | 0.04 | -0.03 | |
2020-06-30 | -0.88 | -0.49 | 0.01 | -0.03 | |
2020-03-31 | -0.86 | -0.48 | 0.04 | -0.02 |
Gross Margins
- marjin kotor untuk InnoCare Pharma Limited pada 2025 Jun 30 adalah 0.88.
- marjin bersih untuk InnoCare Pharma Limited pada 2025 Jun 30 adalah -0.23.
- marjin operasi untuk InnoCare Pharma Limited pada 2025 Jun 30 adalah -0.33.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.88 | -0.23 | -0.33 |
2025-03-31 | 0.86 | -0.44 | -0.33 |
2024-12-31 | 0.86 | -0.42 | -0.70 |
2024-09-30 | 0.86 | -0.60 | -0.87 |
2024-06-30 | 0.85 | -1.06 | -1.07 |
2024-03-31 | 0.83 | -0.85 | -0.95 |
2023-12-31 | 0.80 | -0.81 | -1.09 |
2023-09-30 | 0.79 | -1.15 | -1.00 |
2023-06-30 | 0.77 | -1.15 | -1.00 |
2023-03-31 | 0.77 | -1.12 | -1.08 |
2022-12-31 | 0.75 | -1.96 | -1.61 |
2022-09-30 | 0.90 | -1.96 | -1.61 |
2022-06-30 | 0.94 | -0.25 | -0.22 |
2022-03-31 | 0.94 | -0.16 | -0.17 |
2021-12-31 | 0.90 | -0.06 | -0.17 |
2021-09-30 | 0.90 | -0.24 | -0.06 |
2021-06-30 | 0.90 | -3.31 | -5.38 |
2021-03-31 | 0.91 | -7.74 | -10.70 |
2020-12-31 | 1.00 | -340.02 | -409.81 |
2020-09-30 | 1.00 | -1,314.86 | -349.33 |
2020-06-30 | 1.00 | -1,588.63 | -323.46 |
2020-03-31 | 1.00 | -1,649.17 | -276.50 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |